《盈喜》紫金(02899.HK)料中期純利升54%至232億人幣 股價高開1%
紫金礦業(02899.HK)隔晚(13日)公布,預計2025年半年度實現歸屬於上市公司股東的淨利潤約232億元人民幣(下同),按年增約54%。其中,次季預計實現歸屬於上市公司股東的淨利潤約130億元,按季增約27%。
另外,公司預計2025 年半年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤約215億元,按年增約40%。
公司指,期內當量碳酸鋰產量按年增加29.61倍,礦產銅、礦產金及礦產銀產量分別按年增10%、17%及6%,而礦產鋅(鉛)產量則按年跌9%;而期內礦產金、礦產銅、礦產鋅、礦產銀銷售價格亦按年上升。
紫金今早(14日)高開1%,報20.2元,市前成交824.2萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.